Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
The global Molecular Imaging Agents market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
Report Includes:
This report presents an overview of global market for Molecular Imaging Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Molecular Imaging Agents, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Molecular Imaging Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Molecular Imaging Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Molecular Imaging Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Molecular Imaging Agents sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including General Electric, Bracco Diagnostic, Eisai and Guerbet, etc.
By Company
General Electric
Bracco Diagnostic
Eisai
Guerbet
Segment by Type
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Segment by Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Molecular Imaging Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Imaging Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Molecular Imaging Agents Product Introduction
1.2 Market by Type
1.2.1 Global Molecular Imaging Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Small Molecules
1.2.3 Peptides
1.2.4 Engineered Protein Fragments
1.2.5 Aptamers
1.2.6 Nanoparticles
1.2.7 Others
1.3 Market by Application
1.3.1 Global Molecular Imaging Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Gastrointestinal Disorders
1.3.5 Neurology Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Molecular Imaging Agents Sales Estimates and Forecasts 2018-2029
2.2 Global Molecular Imaging Agents Revenue by Region
2.2.1 Global Molecular Imaging Agents Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Molecular Imaging Agents Revenue by Region (2018-2023)
2.2.3 Global Molecular Imaging Agents Revenue by Region (2024-2029)
2.2.4 Global Molecular Imaging Agents Revenue Market Share by Region (2018-2029)
2.3 Global Molecular Imaging Agents Sales Estimates and Forecasts 2018-2029
2.4 Global Molecular Imaging Agents Sales by Region
2.4.1 Global Molecular Imaging Agents Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Molecular Imaging Agents Sales by Region (2018-2023)
2.4.3 Global Molecular Imaging Agents Sales by Region (2024-2029)
2.4.4 Global Molecular Imaging Agents Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Molecular Imaging Agents Sales by Manufacturers
3.1.1 Global Molecular Imaging Agents Sales by Manufacturers (2018-2023)
3.1.2 Global Molecular Imaging Agents Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Molecular Imaging Agents in 2022
3.2 Global Molecular Imaging Agents Revenue by Manufacturers
3.2.1 Global Molecular Imaging Agents Revenue by Manufacturers (2018-2023)
3.2.2 Global Molecular Imaging Agents Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Molecular Imaging Agents Revenue in 2022
3.3 Global Key Players of Molecular Imaging Agents, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Molecular Imaging Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Molecular Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Molecular Imaging Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Molecular Imaging Agents, Product Offered and Application
3.8 Global Key Manufacturers of Molecular Imaging Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Molecular Imaging Agents Sales by Type
4.1.1 Global Molecular Imaging Agents Historical Sales by Type (2018-2023)
4.1.2 Global Molecular Imaging Agents Forecasted Sales by Type (2024-2029)
4.1.3 Global Molecular Imaging Agents Sales Market Share by Type (2018-2029)
4.2 Global Molecular Imaging Agents Revenue by Type
4.2.1 Global Molecular Imaging Agents Historical Revenue by Type (2018-2023)
4.2.2 Global Molecular Imaging Agents Forecasted Revenue by Type (2024-2029)
4.2.3 Global Molecular Imaging Agents Revenue Market Share by Type (2018-2029)
4.3 Global Molecular Imaging Agents Price by Type
4.3.1 Global Molecular Imaging Agents Price by Type (2018-2023)
4.3.2 Global Molecular Imaging Agents Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Molecular Imaging Agents Sales by Application
5.1.1 Global Molecular Imaging Agents Historical Sales by Application (2018-2023)
5.1.2 Global Molecular Imaging Agents Forecasted Sales by Application (2024-2029)
5.1.3 Global Molecular Imaging Agents Sales Market Share by Application (2018-2029)
5.2 Global Molecular Imaging Agents Revenue by Application
5.2.1 Global Molecular Imaging Agents Historical Revenue by Application (2018-2023)
5.2.2 Global Molecular Imaging Agents Forecasted Revenue by Application (2024-2029)
5.2.3 Global Molecular Imaging Agents Revenue Market Share by Application (2018-2029)
5.3 Global Molecular Imaging Agents Price by Application
5.3.1 Global Molecular Imaging Agents Price by Application (2018-2023)
5.3.2 Global Molecular Imaging Agents Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Molecular Imaging Agents Market Size by Type
6.1.1 US & Canada Molecular Imaging Agents Sales by Type (2018-2029)
6.1.2 US & Canada Molecular Imaging Agents Revenue by Type (2018-2029)
6.2 US & Canada Molecular Imaging Agents Market Size by Application
6.2.1 US & Canada Molecular Imaging Agents Sales by Application (2018-2029)
6.2.2 US & Canada Molecular Imaging Agents Revenue by Application (2018-2029)
6.3 US & Canada Molecular Imaging Agents Market Size by Country
6.3.1 US & Canada Molecular Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Molecular Imaging Agents Sales by Country (2018-2029)
6.3.3 US & Canada Molecular Imaging Agents Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Molecular Imaging Agents Market Size by Type
7.1.1 Europe Molecular Imaging Agents Sales by Type (2018-2029)
7.1.2 Europe Molecular Imaging Agents Revenue by Type (2018-2029)
7.2 Europe Molecular Imaging Agents Market Size by Application
7.2.1 Europe Molecular Imaging Agents Sales by Application (2018-2029)
7.2.2 Europe Molecular Imaging Agents Revenue by Application (2018-2029)
7.3 Europe Molecular Imaging Agents Market Size by Country
7.3.1 Europe Molecular Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Molecular Imaging Agents Sales by Country (2018-2029)
7.3.3 Europe Molecular Imaging Agents Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Molecular Imaging Agents Market Size
8.1.1 China Molecular Imaging Agents Sales (2018-2029)
8.1.2 China Molecular Imaging Agents Revenue (2018-2029)
8.2 China Molecular Imaging Agents Market Size by Application
8.2.1 China Molecular Imaging Agents Sales by Application (2018-2029)
8.2.2 China Molecular Imaging Agents Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Molecular Imaging Agents Market Size by Type
9.1.1 Asia Molecular Imaging Agents Sales by Type (2018-2029)
9.1.2 Asia Molecular Imaging Agents Revenue by Type (2018-2029)
9.2 Asia Molecular Imaging Agents Market Size by Application
9.2.1 Asia Molecular Imaging Agents Sales by Application (2018-2029)
9.2.2 Asia Molecular Imaging Agents Revenue by Application (2018-2029)
9.3 Asia Molecular Imaging Agents Sales by Region
9.3.1 Asia Molecular Imaging Agents Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Molecular Imaging Agents Revenue by Region (2018-2029)
9.3.3 Asia Molecular Imaging Agents Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Molecular Imaging Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Molecular Imaging Agents Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Molecular Imaging Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Molecular Imaging Agents Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Molecular Imaging Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Molecular Imaging Agents Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 General Electric
11.1.1 General Electric Company Information
11.1.2 General Electric Overview
11.1.3 General Electric Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 General Electric Molecular Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 General Electric Recent Developments
11.2 Bracco Diagnostic
11.2.1 Bracco Diagnostic Company Information
11.2.2 Bracco Diagnostic Overview
11.2.3 Bracco Diagnostic Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bracco Diagnostic Molecular Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bracco Diagnostic Recent Developments
11.3 Eisai
11.3.1 Eisai Company Information
11.3.2 Eisai Overview
11.3.3 Eisai Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Eisai Molecular Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eisai Recent Developments
11.4 Guerbet
11.4.1 Guerbet Company Information
11.4.2 Guerbet Overview
11.4.3 Guerbet Molecular Imaging Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Guerbet Molecular Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Guerbet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Molecular Imaging Agents Industry Chain Analysis
12.2 Molecular Imaging Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Molecular Imaging Agents Production Mode & Process
12.4 Molecular Imaging Agents Sales and Marketing
12.4.1 Molecular Imaging Agents Sales Channels
12.4.2 Molecular Imaging Agents Distributors
12.5 Molecular Imaging Agents Customers
13 Market Dynamics
13.1 Molecular Imaging Agents Industry Trends
13.2 Molecular Imaging Agents Market Drivers
13.3 Molecular Imaging Agents Market Challenges
13.4 Molecular Imaging Agents Market Restraints
14 Key Findings in The Global Molecular Imaging Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
General Electric
Bracco Diagnostic
Eisai
Guerbet
听
听
*If Applicable.